Tower Research Capital LLC (Trc) Celldex Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.39 Billion
Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,441 shares of CLDX stock, worth $113,467. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,441

Previous 7,247 38.72%

Holding current value

$113,467

Previous $147,000 22.45%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$20.01 - $26.19 $56,148 - $73,489	-2,806 Reduced 38.72%	4,441 $114,000
Q2 2025 Aug 14, 2025	BUY	$15.13 - $21.65 $81,505 - $116,628	5,387 Added 289.62%	7,247 $147,000
Q1 2025 May 15, 2025	SELL	$18.15 - $27.6 $345,412 - $525,255	-19,031 Reduced 91.1%	1,860 $33,000
Q4 2024 Feb 13, 2025	BUY	$23.31 - $32.4 $237,412 - $329,994	10,185 Added 95.13%	20,891 $527,000
Q3 2024 Nov 14, 2024	SELL	$32.06 - $44.56 $76,815 - $106,765	-2,396 Reduced 18.29%	10,706 $363,000

Q2 2024 Aug 13, 2024	BUY	$32.76 - $42.56 $405,142 - $526,339	12,367 Added 1682.59%	13,102 $484,000
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $83,788 - $123,422	-2,379 Reduced 76.4%	735 $30,000
Q4 2023 Feb 13, 2024	BUY	$22.61 - $40.65 $28,059 - $50,446	1,241 Added 66.26%	3,114 $123,000
Q3 2023 Nov 14, 2023	SELL	$25.45 - $37.46 $63,523 - $93,500	-2,496 Reduced 57.13%	1,873 $51,000
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $66,365 - $83,871	2,191 Added 100.6%	4,369 $148,000
Q1 2023 May 09, 2023	BUY	$34.78 - $47.43 $65,003 - $88,646	1,869 Added 604.85%	2,178 $78,000
Q4 2022 Feb 10, 2023	SELL	$27.78 - $45.38 $180,458 - $294,788	-6,496 Reduced 95.46%	309 $13,000
Q3 2022 Nov 10, 2022	SELL	$22.7 - $37.57 $103,988 - $172,108	-4,581 Reduced 40.23%	6,805 $192,000
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $166,562 - $303,306	8,125 Added 249.16%	11,386 $307,000
Q1 2022 May 12, 2022	SELL	$27.64 - $39.32 $8,817 - $12,543	-319 Reduced 8.91%	3,261 $111,000
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $304,172 - $479,701	-8,525 Reduced 70.43%	3,580 $138,000
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $311,444 - $602,340	10,758 Added 798.66%	12,105 $654,000
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $27,896 - $47,643	1,347 New	1,347 $45,000
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $114,171 - $210,925	-7,052 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $105,709 - $160,433	7,052 New	7,052 $124,000
Q2 2020 Aug 13, 2020	SELL	$1.61 - $13.41 $7,797 - $64,944	-4,843 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.55 - $3.07 $83 - $165	54 Added 1.13%	4,843 $8,000
Q4 2019 Feb 07, 2020	BUY	$2.11 - $2.8 $4,859 - $6,448	2,303 Added 92.64%	4,789 $11,000
Q3 2019 Nov 05, 2019	BUY	$2.05 - $2.75 $5,096 - $6,836	2,486 New	2,486 $5,000
Q2 2019 Aug 13, 2019	SELL	$2.43 - $5.09 $4,201 - $8,800	-1,729 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.45 - $10.35 $5,965 - $17,895	1,729 New	1,729 $9,000

Others Institutions Holding CLDX

# of Institutions

204

Shares Held

66.8M

Call Options Held

222K

Put Options Held

234K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.2B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Celldex Therapeutics, Inc. Transaction History